Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea
· Delayed Price · Currency is KRW 5,970.00
-30.00 (-0.50%)
At close: Jun 19, 2025, 3:30 PM KST
Kyung Dong Pharmaceutical Revenue
Kyung Dong Pharmaceutical had revenue of 45.81B KRW in the quarter ending March 31, 2025, with 1.61% growth. This brings the company's revenue in the last twelve months to 194.66B, up 14.35% year-over-year. In the year 2024, Kyung Dong Pharmaceutical had annual revenue of 193.94B with 19.22% growth.
Revenue (ttm)
194.66B
Revenue Growth
+14.35%
P/S Ratio
0.83
Revenue / Employee
556.18M
Employees
350
Market Cap
161.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 193.94B | 31.26B | 19.22% |
| Dec 31, 2023 | 162.67B | -20.04B | -10.97% |
| Dec 31, 2022 | 182.72B | 5.11B | 2.88% |
| Dec 31, 2021 | 177.61B | 3.78B | 2.18% |
| Dec 31, 2020 | 173.83B | -2.67B | -1.51% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| HD Hyundai Heavy Industries | 15.32T |
| KB Financial Group | 14.93T |